Hydroxymethylene diphosphonate for imaging transthyretin cardiac amyloidosis

J Nucl Cardiol. 2020 Jun;27(3):1040. doi: 10.1007/s12350-019-01719-7. Epub 2019 Apr 10.

Authors

Joseph C Lee^{1

2}, Ramin Alipour³

Affiliations

¹ Department of Medical Imaging, The Prince Charles Hospital, Chermside, QLD, 4032, Australia. Joseph.Lee@health.qld.gov.au.
² Faculty of Medicine, University of Queensland, Brisbane, Australia. Joseph.Lee@health.qld.gov.au.
³ Department of Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Grattan St, Melbourne, VIC, 3000, Australia.

PMID: 30972722
DOI: 10.1007/s12350-019-01719-7

No abstract available

Publication types

Letter
Comment

MeSH terms

Amyloidosis* / diagnostic imaging
Diphosphonates
Humans
Prealbumin*
Radionuclide Imaging

Substances

Diphosphonates
Prealbumin